We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Since opioid overdose death is such a pressing public health issue, harm reduction innovations to prevent overdose death are critical to study. The ambulatory co-prescribing of naloxone is a universal precaution model for all patients prescribed chronic opioid therapy. This can be adapted universally for all patients treated with chronic opioid therapy in an ambulatory setting so that there is increased availability and utilization in the case of an opioid overdose.
————————————————————————————————-
Our newly released issue is now online —> April-June 2017.
————————————————————————————————
–